99 related articles for article (PubMed ID: 11763525)
21. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
Roger M; Attali P; Coquelin JP
Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
[TBL] [Abstract][Full Text] [Related]
22. Long-term polysomnographic study of the efficacy and safety of zolpidem in elderly psychiatric in-patients with insomnia.
Kummer J; Guendel L; Linden J; Eich FX; Attali P; Coquelin JP; Kyrein HJ
J Int Med Res; 1993; 21(4):171-84. PubMed ID: 8112475
[TBL] [Abstract][Full Text] [Related]
23. Zolpidem, a valuable alternative to benzodiazepine hypnotics for chronic insomnia?
Declerck A; Smits M
J Int Med Res; 1999; 27(6):253-63. PubMed ID: 10726234
[TBL] [Abstract][Full Text] [Related]
24. Zolpidem: clinical experience in psychiatric settings.
Undén M
Pol J Pharmacol; 1994; 46(5):483-5. PubMed ID: 7894539
[TBL] [Abstract][Full Text] [Related]
25. Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.
Rosenberg RP
Ann Clin Psychiatry; 2006; 18(1):49-56. PubMed ID: 16517453
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of insomnia related to depressive disorders. Effects of zolpidem versus flunitrazepam administration and withdrawal evaluated in a double-blind study].
Guazzelli M; Ciapparelli A; Balsamo EL; Gemignani A; Sarteschi P
Minerva Psichiatr; 1993 Sep; 34(3):193-203. PubMed ID: 8302193
[TBL] [Abstract][Full Text] [Related]
27. Zolpidem: a review of its use in the management of insomnia.
Swainston Harrison T; Keating GM
CNS Drugs; 2005; 19(1):65-89. PubMed ID: 15651908
[TBL] [Abstract][Full Text] [Related]
28. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
[TBL] [Abstract][Full Text] [Related]
29. Zolpidem for dementia-related insomnia and nighttime wandering.
Shelton PS; Hocking LB
Ann Pharmacother; 1997 Mar; 31(3):319-22. PubMed ID: 9066939
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of insomnia in patients with borderline mental diseases].
Tsivil'ko MA; Korkina MV; Shinaev NN; Volkova NP; Kucherov AIu
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):40-2. PubMed ID: 10629929
[TBL] [Abstract][Full Text] [Related]
31. The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice.
Maarek L; Cramer P; Attali P; Coquelin JP; Morselli PL
J Int Med Res; 1992 Apr; 20(2):162-70. PubMed ID: 1521672
[TBL] [Abstract][Full Text] [Related]
32. Eight weeks of non-nightly use of zolpidem for primary insomnia.
Walsh JK; Roth T; Randazzo A; Erman M; Jamieson A; Scharf M; Schweitzer PK; Ware JC
Sleep; 2000 Dec; 23(8):1087-96. PubMed ID: 11145323
[TBL] [Abstract][Full Text] [Related]
33. A postmarketing surveillance study of zopiclone in insomnia.
Mahendran R; Chee KT; Peh LH; Wong KE; Lim L
Singapore Med J; 1994 Aug; 35(4):390-3. PubMed ID: 7899899
[TBL] [Abstract][Full Text] [Related]
34. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
Jhaveri M; Seal B; Pollack M; Wertz D
Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740
[TBL] [Abstract][Full Text] [Related]
35. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
Barkin RL
Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
[TBL] [Abstract][Full Text] [Related]
36. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
[TBL] [Abstract][Full Text] [Related]
37. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference.
Black J; Pillar G; Hedner J; Polo O; Berkani O; Mangialaio S; Hmissi A; Zammit G; Hajak G
Sleep Med; 2017 Aug; 36():86-94. PubMed ID: 28735928
[TBL] [Abstract][Full Text] [Related]
39. Variability in home-measured blood pressure and heart rate: associations with self-reported insomnia and sleep duration.
Johansson JK; Kronholm E; Jula AM
J Hypertens; 2011 Oct; 29(10):1897-905. PubMed ID: 21841496
[TBL] [Abstract][Full Text] [Related]
40. Zaleplon: a review of its use in the treatment of insomnia.
Dooley M; Plosker GL
Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
